Fiera Capital (Canada)
EDIT icon

Fiera Capital (Canada)’s Editas Medicine EDIT Stock Holding History

Fiera Capital (Canada)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,155
Closed -$768K – 675
2018
Q3 		$768K Sell
24,155
-14,857
-38% -$480K ﹤0.01% 510
2018
Q2 		$1.4M Sell
39,012
-3,290
-8% -$116K 0.01% 440
2018
Q1 		$1.4M Buy
+42,302
New +$1.51M 0.01% 427

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Fiera Capital (Canada)'s EDIT Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of Editas Medicine (EDIT) in Q4 2018, closing a stake of 24,155 shares — an estimated $768K sold.

Fiera Capital (Canada) first reported a position in EDIT in Q1 2018 and held it in 3 quarters. The position peaked at $1.4M in Q1 2018. 194 funds tracked by Wall St. Rank hold EDIT as of Q4 2018.

  • Fiera Capital (Canada) reported no remaining Editas Medicine position as of Q4 2018 after selling out during the quarter.
  • Fiera Capital (Canada) sold 24,155 Editas Medicine shares in Q4 2018, an estimated $768K.
  • Fiera Capital (Canada) first reported a position in Editas Medicine in Q1 2018 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Editas Medicine position peaked at $1.4M in Q1 2018.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.